Filing Flows › Cryoport (CYRX) › Q2 2026
Cryoport (CYRX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Cryoport (CYRX) reported revenue of $49.0M for the second quarter 2026 (Q2 2026), +8% from a year earlier and +2% from the quarter before. Operating margin was -20.5%, net loss $8.3M (16.9% of revenue).
Cryoport, Q2 2026: revenue $49.0M (+8% year over year), operating margin -20.5%, net loss $8.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $49.0M | +2% | +8% |
| Operating profit | −$10.0M | — | — |
| Net earnings | −$8.3M | — | -108% |
| Operating cash flow | $1.1M | -70% | — |
What changed
Revenue was $49.0M in Q2 2026, up 8% year over year and up 2% from the previous quarter. BioLogistics Solutions was the largest line at 46% of revenue. BioLogistics Solutions added $2.5M year over year (up 13%), 71% of the total change.
Gross margin was 46.6%, down 0.4 points from Q2 2025. Operating costs exceeded revenue by $10.0M, an operating margin of -20.5%. Operating expenses grew 6% against revenue growth of 8%. The fastest-growing cost line was Research & development (+18%). The quarter ended with a net loss of $8.3M, narrower than the previous quarter's $10.5M loss. Non-operating items added $2.3M, -30% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $1.1M. Non-cash charges added back $6.6M of depreciation and amortization and $2.4M of share-based compensation. Working capital and other items added $395K. Capital expenditures of $9.1M exceeded it, leaving free cash flow of −$8.0M.
Questions
What was Cryoport's revenue in the second quarter 2026?
Cryoport (CYRX) reported revenue of $49.0M for the second quarter 2026 (Q2 2026), +8% from a year earlier and +2% from the quarter before.
Was Cryoport profitable in the second quarter 2026?
Operating loss was $10.0M (-20.5% of revenue) and net loss $8.3M.
Source: Cryoport 10-Q on SEC EDGAR.